Nanomix launches trial of eLab analyzer and panel

LabPulse.com staff writers
Jun 22, 2022
2021 10 06 20 31 5504 Nanotechnology 400

Nanomix has launched a trial in Spain to evaluate its eLab mobile immunoassay diagnostic system and S1 Panel assay for the detection of critical infections.

The company's eLab system is a mobile, handheld immunoassay and chemistry diagnostic system designed for rapid point-of-care testing, while the S1 Panel Cartridge was developed to aid in diagnosing critical infections, including sepsis. The panel provides quantitative test results for procalcitonin (PCT), C-reactive protein (CRP), and lactate (LAC) from a single venous whole blood or plasma sample type.

The trial will be conducted at the emergency department of Hospital Clinico San Carlos in Madrid.

Latest in Sepsis
Sepsis Bacteria Social
Researchers map protein biomarkers in sepsis fight
April 2, 2024
Visit our Molecular Diagnostics Community
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
Sepsis Bacteria Social
Program to fight sepsis in LMICs launched at SCCM Congress, test data presented
January 26, 2024
Sepsis Bacteria Social
Siemens Healthineers contracts with NIAID to develop NGS-based sepsis test
November 22, 2023
Related Stories
2020 03 18 20 13 7386 Virus Coronavirus Covid 19 400
Emergency Use Authorization
Nanomix, Mobility to develop COVID-19 antibody POC test
2020 06 19 20 57 0712 Sepsis Bacteria 400
Sepsis
Abionic nabs IVDR certification for sepsis test
2022 07 29 16 04 7496 Shah 400
510(k)
Video from AACC: Cytovale immune-response test for sepsis
Visit our Molecular Diagnostics Community
Sponsor Content
Visit our Molecular Diagnostics Community
More in Sepsis
Researchers map protein biomarkers in sepsis fight
By Liz Carey
Swedish researchers are mapping patterns of protein biomarkers in sepsis that could be useful for simple blood tests in the emergency department, according to research to be presented at ECCMID 2024.
April 2, 2024
Sepsis Bacteria Social
Cytokine improves outcomes in mice with sepsis, predicts survival in humans
By Nick Paul Taylor
Administering a protein that correlates to survival in sepsis has improved survival in mice in a study, pointing to a potential new way to treat the life-threatening reaction to infection.
February 6, 2024
Antigen Tcell Cytokines Social
Program to fight sepsis in LMICs launched at SCCM Congress, test data presented
By Matt Limb
Intensive care professionals have unveiled a program to cut deaths from sepsis in low- and middle-income countries (LMICs) with ambitions to improve access to diagnostic tools, laboratories, and medicines.
January 26, 2024
Sepsis Bacteria Social
Siemens Healthineers contracts with NIAID to develop NGS-based sepsis test
By LabPulse.com staff writers
Siemens Healthineers has secured a three-year, $5.5 million contract with the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. National Institutes of Health, to develop a test to improve sepsis treatment.
November 22, 2023
Sepsis Bacteria Social
Nanopore Technologies, Day Zero Diagnostics to collaborate on sepsis diagnostic solution
By Matt Limb
Oxford, U.K.-based Oxford Nanopore Technologies and Boston-based infectious disease diagnostics firm Day Zero Diagnostics have announced a partnership to develop an end-to-end solution for the diagnosis of bloodstream infections.
November 20, 2023
Bacteria Blood Sepsis Social
Cytovale raises $84M in series C funding
By LabPulse.com staff writers
Medical technology firm Cytovale has raised $84 million in a series C financing round that the firm says it will use to expand the commercialization of its 10-minute IntelliSep test.
November 16, 2023
Money Hundred Bills Social
Some emergency sepsis screening tools inadequate, EU study suggests
By Matt Limb
Two out of the four internationally recommended screening tools used by emergency medical services are inadequate for recognizing sepsis, say German researchers.
September 26, 2023
Sepsis Bacteria Social
Nonprofit health system adopts Immunexpress test for detecting sepsis
By Nick Paul Taylor
FirstHealth of the Carolinas, a nonprofit health system licensed for four hospitals in North Carolina, will use Immunexpress’ SeptiCyte Rapid test to help differentiate sepsis-positive cases from patients with infection-negative systemic inflammation.
August 23, 2023
Bacteria Blood Sepsis Social
Prenosis nabs $749K federal contract to study clinical utility of AI-based diagnostic tool for sepsis
By Leo O'Connor
The firm’s Sepsis ImmunoScore is a pathogen-agnostic, host-based digital diagnostic tool that uses artificial intelligence/machine learning to predict sepsis using clinical parameters and protein biomarkers.
June 7, 2023
Artificial Intelligence Ai Social
T2 Biosystems seeking FDA breakthrough device designation for Candida auris test
By LabPulse.com staff writers
The Lexington, MA-based maker of a molecular platform and tests for sepsis and other bloodstream infections recently announced plans to add Candida auris detection to its FDA-cleared T2Candida Panel.
June 6, 2023
Bacteria Blood Sepsis Social
Asep Medical Holdings aims for Nasdaq listing
By LabPulse.com staff writers
Sepset Biosciences, an Asep Medical business, is preparing for clinical studies aimed at the commercialization of a diagnostic test. The test leverages gene expression to predict the development of severe sepsis.
May 31, 2023
Earning Stock Market Social
Validation data presented for Cytovale sepsis diagnostic test
By Elissa Wolfson
The lead investigator has presented the results of a study to validate a rapid diagnostic test that detects sepsis in the emergency department. The study data were used to obtain FDA clearance for the test last December.
May 24, 2023
Diagnose Sepsis Social
Page 1 of 6
Next Page